Insider Shareholders with Direct Ownership of Lexicon Pharmaceuticals, Inc. (LXRX)
This section provides a comprehensive overview of the insiders with direct ownership of Lexicon Pharmaceuticals, Inc. (LXRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LEXICON PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Raymond Debbane
Director |
1,068,806 | 0 | 1,385,689 $1.03 Million | 8 |
May 13, 2025
Added 2.59%
|
|
Lonnel Coats
Chief Executive Officer |
1,014,635 | 215,433 | 1,098,068 $812,570 | 14 |
Feb 28, 2024
Reduced 5.29%
|
|
Alan J Main
EVP, Innov & Chem Sciences |
363,421 | 128,957 | 339,104 $250,936 | 10 |
Feb 28, 2025
Reduced 11.35%
|
|
Jeffrey L Wade
President and COO |
333,522 | 120,303 | 324,214 $239,918 | 10 |
Feb 28, 2024
Reduced 10.41%
|
|
Philippe Amouyal
Director |
68,806 | 0 | 285,174 $211,028 | 5 |
May 13, 2025
Added 11.43%
|
|
Brian T Crum
SVP, General Counsel & Secr. |
332,765 | 121,682 | 260,815 $193,003 | 10 |
Feb 28, 2025
Reduced 14.89%
|
|
Christopher J Sobecki
Director |
68,806 | 0 | 203,865 $150,860 | 5 |
May 13, 2025
Added 15.29%
|
|
Kenneth B. Kassler Taub
SVP, Regulatory & QA |
156,914 | 56,712 | 162,672 $120,377 | 6 |
Feb 28, 2024
Reduced 13.02%
|
|
Sam L Barker
Director |
68,806 | 0 | 124,459 $92,099 | 5 |
May 13, 2025
Added 22.83%
|
|
Wendy Mc Dermott
SVP, Human Resources |
180,540 | 58,894 | 121,646 $90,018 | 8 |
Feb 28, 2025
Reduced 19.79%
|
|
Praveen Tyle
EVP, R&D |
68,007 | 16,560 | 120,791 $89,385 | 2 |
Feb 28, 2021
Reduced 12.06%
|
|
Craig B Granowitz
SVP, Chief Medical Officer |
229,557 | 109,305 | 120,252 $88,986 | 6 |
Feb 28, 2025
Reduced 35.2%
|
|
Judith L Swain
Director |
68,806 | 0 | 85,174 $63,028 | 5 |
May 13, 2025
Added 30.18%
|
|
Kristen Alexander
VP, Finance and Accounting |
105,690 | 38,322 | 76,368 $56,512 | 8 |
Feb 28, 2025
Reduced 18.96%
|
|
James F Tessmer
VP, Finance & Accounting |
40,316 | 33,677 | 71,766 $53,106 | 4 |
Mar 15, 2021
Reduced 14.33%
|
|
Kiernan Seth
VP, Chief Commercial Officer |
73,210 | 20,074 | 53,136 $39,320 | 4 |
Feb 28, 2023
Reduced 18.19%
|
|
Robert J Md Lefkowitz
Director |
31,996 | 0 | 48,364 $35,789 | 4 |
Apr 28, 2024
Added 14.24%
|
|
Alan S Nies
Director |
23,964 | 0 | 41,046 $30,374 | 3 |
May 21, 2023
Added 18.48%
|
|
Frank Palantoni
Director |
23,964 | 0 | 40,332 $29,845 | 3 |
May 21, 2023
Added 18.74%
|
|
Diane E. Sullivan
Director |
36,810 | 0 | 36,810 $27,239 | 1 |
May 13, 2025
Added 50.0%
|
|
Lisa De Francesco
SVP, IR and Corp Comm |
24,673 | 9,096 | 15,577 $11,526 | 2 |
Feb 28, 2025
Reduced 36.87%
|
|
C.V. Invus
Director |
0 | 4,321,214 | 0 $0 | 1 |
Dec 31, 2020
Reduced 100.0%
|